Why the study?
Insertable cardiac monitors generate high transmission volumes that increase clinical workload, but real-world data on using remote reprogramming to reduce transmission burden and in-office visits were lacking.
Does remote reprogramming of insertable cardiac monitors reduce transmission burden in patients?
Does remote reprogramming of insertable cardiac monitors reduce transmission burden in patients?
Remote reprogramming of insertable cardiac monitors is utilized in 39% of real-world cases and can significantly reduce remote monitoring transmission burden.
Background: Insertable cardiac monitors (ICMs) enable continuous arrhythmia monitoring but generate high transmission volumes, increasing clinical workload. The LUX-Dx ICM (Boston Scientific) allows remote reprogramming of device alert settings, potentially reducing in-office visits. Objective: This study aimed to evaluate the real-world use of remote reprogramming after its initial commercialization in Europe and its impact on transmission burden. Methods: Deidentified data were collected from 697 consecutive patients across 23 European centers between 2022 and 2024. Conclusion: ICM reprogramming plays a key role in optimizing device performance and reducing remote monitoring burden. Currently used in 39% of cases, remote reprogramming holds potential for broader adoption to minimize in-office visits. Efficiency may be further improved by transitioning to an alert-based monitoring strategy and eliminating scheduled transmissions.
No takes yet. Share an insight, caveat, or question.
Fareh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Heart Rhythm O2